Inventor · disambiguated record
Eric Verdin
Also filed as: VERDIN ERIC · VERDIN ERIC M
22 granted patents·14 pending applications·55 citations·filing 2001–2023
93Inventor score
Files withDAVID GLADSTONE INST12THE J DAVID GLADSTONE INST6VERDIN ERIC M5UNIV CALIFORNIA4BUCK INST RES AGING2
Top patents by PatentIndex Score
36 records- 0192US10562839B2Medium chain fatty acid esters of β-hydroxybutyrate and butanediol and compositions and methods for using sameTHE J DAVID GLADSTONE INST·Filed 2019·Granted Feb 18, 2020·8 cites·30 claims
- 0287US10647658B2Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using sameTHE J DAVID GLADSTONE INST·Filed 2019·Granted May 12, 2020·5 cites·30 claims
- 0385US11608308B2Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using sameTHE J DAVID GLADSTONE INST·Filed 2020·Granted Mar 21, 2023·1 cites·28 claims
- 0483US10889538B2Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using sameTHE J DAVID GLADSTONE INST·Filed 2017·Granted Jan 12, 2021·3 cites·27 claims
- 0581US7482016B2Immunogenic compositions comprising HIV-1 acetylated Tat polypeptidesDAVID GLADSTONE INST·Filed 2004·Granted Jan 27, 2009·13 cites·26 claims
- 0678US7485416B2Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activityUNIV CALIFORNIA·Filed 2004·Granted Feb 3, 2009·6 cites·16 claims
- 0777US11773051B2S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using sameBUCK INST RES AGING·Filed 2018·Granted Oct 3, 2023·2 cites·16 claims
- 0876US7351542B2Methods of modulating tubulin deacetylase activityUNIV CALIFORNIA·Filed 2003·Granted Apr 1, 2008·4 cites·6 claims
- 0975US7544467B2Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV)DAVID GLADSTONE INST·Filed 2007·Granted Jun 9, 2009·1 cites·6 claims
- 1073US8748464B2Use of SIRT1 activators or inhibitors to modulate an immune responseVERDIN ERIC M·Filed 2010·Granted Jun 10, 2014·2 cites·7 claims
- 1172US7488587B2Histone deacetylase and methods of use thereofDAVID GLADSTONE INST·Filed 2002·Granted Feb 10, 2009·4 cites·12 claims
- 1272US7232685B2Cell lines with latent immunodeficiency virus and methods of use thereofDAVID GLADSTONE INST·Filed 2002·Granted Jun 19, 2007·2 cites·13 claims
- 1371US7745173B2Histone deacetylase and methods of use thereofDAVID GLADSTONE INST·Filed 2008·Granted Jun 29, 2010·1 cites·14 claims
- 1468US7081343B2Methods for identifying modulators of NF-KB activityUNIV CALIFORNIA·Filed 2001·Granted Jul 25, 2006·1 cites·18 claims
- 1567US7273713B2Methods of modulating mitochondrial NAD-dependent deacetylaseUNIV CALIFORNIA·Filed 2003·Granted Sep 25, 2007·1 cites·12 claims
- 1660US2025282707A1Novel ketone ester compoundsBUCK INST RES AGING·Filed 2023·Application pending·0 cites
- 1760US2009306131A1Cell lines with latent immunodeficiency virus and methods of use thereofVERDIN ERIC·Filed 2007·Application pending·0 cites
- 1859US8518635B2Regulation of protein activity by reversible acetylationSCHWER BJOERN·Filed 2007·Granted Aug 27, 2013·1 cites·19 claims
- 1959US7884081B2Methods of modulating tubulin deacetylast activityDAVID GLADSTONE INST·Filed 2008·Granted Feb 8, 2011·0 cites·14 claims
- 2059US2008171797A1Methods of modulating mitochondrial nad-dependent deacetylaseVERDIN ERIC M·Filed 2007·Application pending·0 cites
- 2159US2008076835A1Methods of modulating mitochondrial nad-dependent deacetylaseVERDIN ERIC M·Filed 2007·Application pending·0 cites
- 2253US10004753B2Methods for treating tauopathyTHE J DAVID GLADSTONE INST·Filed 2016·Granted Jun 26, 2018·0 cites·20 claims
- 2353US2010160262A1Compositions and methods for modulating sirtuin activityOTT MELANIE·Filed 2008·Application pending·0 cites
- 2453US2008200566A1Dephosphorylation of HDAC7 By Myosin PhosphataseDAVID GLADSTONE INST·Filed 2007·Application pending·0 cites
- 2552US2014030295A1Use of Sirt1 Activators or Inhibitors to Modulate an Immune ResponseDAVID GLADSTONE INST·Filed 2012·Application pending·0 cites
- 2652US2015024955A1Methods of Identifying Modulators of Dephosphorylation of Histone DeacetylaseDAVID GLADSTONE INST·Filed 2014·Application pending·0 cites
- 2749US2014303074A1Compositions and Methods For Inhibiting Immunodeficiency Virus TranscriptionDAVID GLADSTONE INST·Filed 2012·Application pending·0 cites
- 2849US2015133434A1Compositions and Methods for Reactivating Latent Immunodeficiency VirusDAVID GLADSTONE INST·Filed 2013·Application pending·0 cites
- 2948US2022193209A1Compositions and methods for reactivating latent immunodeficiency virus and/or treating immunodeficiency virus infectionTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADS·Filed 2020·Application pending·0 cites
- 3047US8114853B2Methods of treating smooth muscle cell disordersVERDIN ERIC M·Filed 2009·Granted Feb 14, 2012·0 cites·13 claims
- 3146US9474788B2Methods for the reactivation of latent HIV using cytosine methylation inhibitors and NF-KB activatorsVERDIN ERIC M·Filed 2011·Granted Oct 25, 2016·0 cites·7 claims
- 3244US10106818B2Dual-color HIV reporter system for the detection of latently-infected cellsTHE J DAVID GLADSTONE INST·Filed 2014·Granted Oct 23, 2018·0 cites·15 claims
- 3344US2012028912A1Methods of modulating bromodomainsZHOU MING-MING·Filed 2009·Application pending·0 cites
- 3442US12509451B2Heteroaryl amide inhibitors of CD38NAPA THERAPEUTICS LTD·Filed 2021·Granted Dec 30, 2025·0 cites·24 claims
- 3539US2004009613A1Methods of identifying modulators of bromodomainsFiled 2002·Application pending·0 cites
- 3638US2006051815A1Methods of treating smooth muscle cell disordersDAVID GLADSTONE INST·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Verdin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →